J. Invest. Dermatol. 2020 Jan 28
Apremilast in combination to narrowband UVB in the treatment of vitiligo. A 52 weeks monocentric prospective randomized placebo-controlled study.
Khemis A, Fontas E, Moulin S, Montaudié H, Lacour JP, Passeron T
Scientific rationale and encouraging first clinical results suggest the interest of using apremilast for treating vitiligo. ...
Read More
Source: PubMed
Wound Repair Regen 2020 Jan 31
Lesional skin in vitiligo exhibits delayed in vivo re-epithelialization compared to the non-lesional skin.
Gupta A, Chauhan A, Priya A, Mantri B, Wadhokar M, Dalave K, Shah B, Gokhale RS, Batra VV, Singh A
Vitiligo, a common skin disorder, is characterized by the loss of functional melanocytes resulting in the depigmentation of skin. Previous studies hav ...
Read More
Source: PubMed
Ann Dermatol Venereol
Cribier B
Atopic dermatitis is associated with an increased risk of asthma (10 to 30% according to age), allergic rhinitis and conjunctivitis and food allergy. ...
Read More
Source: PubMed
Dermatol Ther 2020 Jan 29
Refractory vitiligo improving with Eculizumab.
Martinez-Cabriales SA, Bohdanowicz M, Wells R, Shear NH
Read More
Source: PubMed
J Cosmet Dermatol 2020 Jan 30
Noncultured epidermal suspensions obtained from partial-thickness epidermal cuts and suction blister roofs for vitiligo treatment: A prospective comparative study.
Anbar TS, El-Ammawi TS, Mohammed SS, Abdel-Rahman AT
The treatment options for vitiligo are either nonsurgical, including medical treatments and phototherapy, or surgical, including autologous transplant ...
Read More
Source: PubMed
J. Invest. Dermatol. 2020 Jan 28
Apremilast in combination to narrowband UVB in the treatment of vitiligo. A 52 weeks monocentric prospective randomized placebo-controlled study.
Khemis A, Fontas E, Moulin S, Montaudié H, Lacour JP, Passeron T
Scientific rationale and encouraging first clinical results suggest the interest of using apremilast for treating vitiligo. ...
Read More
Source: PubMed
Wound Repair Regen 2020 Jan 31
Lesional skin in vitiligo exhibits delayed in vivo re-epithelialization compared to the non-lesional skin.
Gupta A, Chauhan A, Priya A, Mantri B, Wadhokar M, Dalave K, Shah B, Gokhale RS, Batra VV, Singh A
Vitiligo, a common skin disorder, is characterized by the loss of functional melanocytes resulting in the depigmentation of skin. Previous studies hav ...
Read More
Source: PubMed
Ann Dermatol Venereol
Cribier B
Atopic dermatitis is associated with an increased risk of asthma (10 to 30% according to age), allergic rhinitis and conjunctivitis and food allergy. ...
Read More
Source: PubMed
Dermatol Ther 2020 Jan 29
Refractory vitiligo improving with Eculizumab.
Martinez-Cabriales SA, Bohdanowicz M, Wells R, Shear NH
Read More
Source: PubMed
J Cosmet Dermatol 2020 Jan 30
Noncultured epidermal suspensions obtained from partial-thickness epidermal cuts and suction blister roofs for vitiligo treatment: A prospective comparative study.
Anbar TS, El-Ammawi TS, Mohammed SS, Abdel-Rahman AT
The treatment options for vitiligo are either nonsurgical, including medical treatments and phototherapy, or surgical, including autologous transplant ...
Read More
Source: PubMed
J. Invest. Dermatol. 2020 Jan 28
Apremilast in combination to narrowband UVB in the treatment of vitiligo. A 52 weeks monocentric prospective randomized placebo-controlled study.
Khemis A, Fontas E, Moulin S, Montaudié H, Lacour JP, Passeron T
Scientific rationale and encouraging first clinical results suggest the interest of using apremilast for treating vitiligo. ...
Read More
Source: PubMed
Wound Repair Regen 2020 Jan 31
Lesional skin in vitiligo exhibits delayed in vivo re-epithelialization compared to the non-lesional skin.
Gupta A, Chauhan A, Priya A, Mantri B, Wadhokar M, Dalave K, Shah B, Gokhale RS, Batra VV, Singh A
Vitiligo, a common skin disorder, is characterized by the loss of functional melanocytes resulting in the depigmentation of skin. Previous studies hav ...
Read More
Source: PubMed
Ann Dermatol Venereol
Cribier B
Atopic dermatitis is associated with an increased risk of asthma (10 to 30% according to age), allergic rhinitis and conjunctivitis and food allergy. ...
Read More
Source: PubMed
Dermatol Ther 2020 Jan 29
Refractory vitiligo improving with Eculizumab.
Martinez-Cabriales SA, Bohdanowicz M, Wells R, Shear NH
Read More
Source: PubMed
J. Invest. Dermatol. 2020 Jan 28
Apremilast in combination to narrowband UVB in the treatment of vitiligo. A 52 weeks monocentric prospective randomized placebo-controlled study.
Khemis A, Fontas E, Moulin S, Montaudié H, Lacour JP, Passeron T
Scientific rationale and encouraging first clinical results suggest the interest of using apremilast for treating vitiligo. ...
Read More
Source: PubMed
J Cosmet Dermatol 2020 Jan 30
Noncultured epidermal suspensions obtained from partial-thickness epidermal cuts and suction blister roofs for vitiligo treatment: A prospective comparative study.
Anbar TS, El-Ammawi TS, Mohammed SS, Abdel-Rahman AT
The treatment options for vitiligo are either nonsurgical, including medical treatments and phototherapy, or surgical, including autologous transplant ...
Read More
Source: PubMed
Wound Repair Regen 2020 Jan 31
Lesional skin in vitiligo exhibits delayed in vivo re-epithelialization compared to the non-lesional skin.
Gupta A, Chauhan A, Priya A, Mantri B, Wadhokar M, Dalave K, Shah B, Gokhale RS, Batra VV, Singh A
Vitiligo, a common skin disorder, is characterized by the loss of functional melanocytes resulting in the depigmentation of skin. Previous studies hav ...
Read More
Source: PubMed
Ann Dermatol Venereol
Cribier B
Atopic dermatitis is associated with an increased risk of asthma (10 to 30% according to age), allergic rhinitis and conjunctivitis and food allergy. ...
Read More
Source: PubMed
J. Invest. Dermatol. 2020 Jan 28
Apremilast in combination to narrowband UVB in the treatment of vitiligo. A 52 weeks monocentric prospective randomized placebo-controlled study.
Khemis A, Fontas E, Moulin S, Montaudié H, Lacour JP, Passeron T
Scientific rationale and encouraging first clinical results suggest the interest of using apremilast for treating vitiligo. ...
Read More
Source: PubMed
Dermatol Ther 2020 Jan 29
Refractory vitiligo improving with Eculizumab.
Martinez-Cabriales SA, Bohdanowicz M, Wells R, Shear NH
Read More
Source: PubMed
Wound Repair Regen 2020 Jan 31
Lesional skin in vitiligo exhibits delayed in vivo re-epithelialization compared to the non-lesional skin.
Gupta A, Chauhan A, Priya A, Mantri B, Wadhokar M, Dalave K, Shah B, Gokhale RS, Batra VV, Singh A
Vitiligo, a common skin disorder, is characterized by the loss of functional melanocytes resulting in the depigmentation of skin. Previous studies hav ...
Read More
Source: PubMed
J Cosmet Dermatol 2020 Jan 30
Noncultured epidermal suspensions obtained from partial-thickness epidermal cuts and suction blister roofs for vitiligo treatment: A prospective comparative study.
Anbar TS, El-Ammawi TS, Mohammed SS, Abdel-Rahman AT
The treatment options for vitiligo are either nonsurgical, including medical treatments and phototherapy, or surgical, including autologous transplant ...
Read More
Source: PubMed
Ann Dermatol Venereol
Cribier B
Atopic dermatitis is associated with an increased risk of asthma (10 to 30% according to age), allergic rhinitis and conjunctivitis and food allergy. ...
Read More
Source: PubMed
Dermatol Ther 2020 Jan 29
Refractory vitiligo improving with Eculizumab.
Martinez-Cabriales SA, Bohdanowicz M, Wells R, Shear NH
Read More
Source: PubMed
J Cosmet Dermatol 2020 Jan 30
Noncultured epidermal suspensions obtained from partial-thickness epidermal cuts and suction blister roofs for vitiligo treatment: A prospective comparative study.
Anbar TS, El-Ammawi TS, Mohammed SS, Abdel-Rahman AT
The treatment options for vitiligo are either nonsurgical, including medical treatments and phototherapy, or surgical, including autologous transplant ...
Read More
Source: PubMed
